Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews


Print Page Follow BioNews on Twitter BioNews RSS feed

Like the Progress Educational Trust on Facebook



King's College London - Health: More than a medical matter





First patients receive eye stem cell transplants in attempt to restore sight

28 May 2012

By Ana Pallesen

Appeared in BioNews 658

Two patients with corneal blindness have become the first people in the UK to have stem cells transplanted into their eyes in order to restore their sight.

Patients have scarred and damaged parts of their corneas removed from their eyes before the stem cell transplant takes place. The stem cells are grown from deceased donors' eye tissue for around two weeks prior to the three-hour operation.

Doctors are 'very impressed' with the results so far, according to The Scotsman. It is hoped the procedure will not only be used to restore sight in people with debilitating eye diseases, but also to treat those born blind.

Mrs Sylvia Paton was the first patient to receive this treatment 12 weeks ago. She has aniridia, a condition where the eye's iris is incompletely formed, meaning she has only 10 percent of the vision of a sighted person and is extremely short-sighted.

She told the Independent: 'Even if only a little of my vision is restored, it would be better than nothing. Plus, it means that the team has gained valuable experience'.

Dr Ashish Agrawal, a consultant ophthalmologist at NHS Lothian who carried out this transplant, reported that Paton was recovering well, and that they would know if the trial had been a success within nine months.

'However, this is the first and the major step in the complex visual rehabilitation process and she will require further surgical treatment to restore vision', he told the Independent.

Corneal diseases are thought to be the second biggest cause of blindness, after cataracts, with 20 million people being affected worldwide.

'This pioneering new treatment could potentially restore sight and improve the lives of many patients, and it is vital that we continue to invest in innovative projects such as this one', commented Scottish Health Secretary Nicola Sturgeon.

The trial, which has recruited a total of 20 patients, including the two who have already had the operation, is costing £500,000 and has been funded by the UK Stem Cell Foundation and Scottish Enterprise, with the stem cells being grown by the Scottish National Blood Transfusion Service.

 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

07 April 2014 - by Amy Reed 
In this week's episode of The Life Scientific, presenter (and physicist) Professor Jim Al-Khalili interviews the recently retired geneticist and discoverer of the PAX6 gene, Professor Veronica van Heyningen.... [Read More]
16 September 2013 - by Siobhan Chan 
A blood test for children born with cataracts will allow faster diagnosis and more personalised treatment, according to researchers at the British Society for Genetic Medicine's annual conference... [Read More]
29 July 2013 - by Greg Ball 
Light-sensitive cells found in the retina have been grown from mouse embryonic stem cells (ESCs) and successfully transplanted into the eyes of visually impaired mice, restoring some vision... [Read More]
18 February 2013 - by Maria Sheppard 
Twenty-four genes linked to short-sightedness have been identified by an international consortium of scientists... [Read More]
25 June 2012 - by Dr Daniel Grimes 
Human embryonic stem cells have, for the first time, been used to grow a crucial part of the eye, a paper in Cell Stem Cell reports. It is hoped that in the future transplantation of such tissue could help visually impaired people recover their sight... [Read More]

12 March 2012 - by Dr Nadeem Shaikh 
A potential stem cell therapy for glaucoma – a degenerative eye condition that can lead to blindness – has yielded positive results in animal tests... [Read More]
13 February 2012 - by Maria Botcharova 
Three women have reported a significant improvement in sight following gene therapy in both their eyes. Initially, they received the therapy in just one eye, but this latest study demonstrates the treatment was also successful in the other... [Read More]
06 February 2012 - by Ruth Retassie 
US company StemCells Inc have received Food and Drug Administration (FDA) authorisation to carry out clinical trials of their treatment for one of the leading causes of blindness in over 55-year-olds... [Read More]
31 January 2012 - by Dr Dusko Ilic and Dr Emma Stephenson 
Last week, Advanced Cell Technology (ACT) of Massachusetts, USA, made two important announcements regarding human embryonic stem (hES) cell-based therapies for the potential treatment of Stargardt's dystrophy and age-related macular degeneration, two devastating degenerative disease leading to blindness.... [Read More]
31 January 2012 - by Rosemary Paxman 
A clinical trial testing the safety of using human embryonic stem cell (hESC) in the treatment of progressive eye conditions has been carried out by researchers in the USA... [Read More]

HAVE YOUR SAY
Be the first to have your say.

You need to Login or Register to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions

 


 

- click here to enquire about using this story.

Printer Friendly Page

Published by the Progress Educational Trust
RISK ASSESSMENT:
BREAST CANCER, PREDICTION AND SCREENING
FREE public event in central London, 6.30pm on Thursday 8 May 2014 - find out more HERE

ANNIVERSARY APPEAL
Please donate HERE, so that the Progress Educational Trust can continue throughout 2014 (and beyond) while keeping BioNews FREE for you to read

The Progress Educational Trust was shortlisted for the Charity Times Awards 2011

Advertise your products and services HERE - click for further details

Good Fundraising Code

Become a Friend of PET HERE, and give the Progress Educational Trust a regular donation